Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Capital Employed (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 3 years of Return on Capital Employed data on record, last reported at 0.05% in Q3 2022.

  • For Q3 2022, Return on Capital Employed fell 2.0% year-over-year to 0.05%; the TTM value through Sep 2022 reached 0.05%, down 2.0%, while the annual FY2021 figure was 0.18%, N/A changed from the prior year.
  • Return on Capital Employed reached 0.05% in Q3 2022 per AVIR's latest filing, up from 0.04% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.18% in Q4 2021 and bottomed at 0.06% in Q4 2020.
  • Average Return on Capital Employed over 3 years is 0.06%, with a median of 0.05% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: rose 25bps in 2021, then fell -4bps in 2022.
  • A 3-year view of Return on Capital Employed shows it stood at 0.06% in 2020, then soared by 386bps to 0.18% in 2021, then tumbled by -76bps to 0.05% in 2022.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.05% in Q3 2022, 0.04% in Q2 2022, and 0.09% in Q1 2022.